Top 100 Publications as Measured by Altmetrics in the Field of Central Nervous System Inflammatory Demyelinating Disease

Table 6

Topics on treatment and risk factor of central nervous system inflammatory demyelinating disease that achieved high attention in social outlets.

Category	Specific topic
Treatment	Haemopoietic stem cell transplantation
	B-cell depleting agents (ocrelizumab and alemtuzumab)
	Siponimod
	Oral cladribine
	Sphingosine 1-phosphate receptor modulator ozanimod
	Estriol combined with glatiramer acetate
	High-dose simvastatin
	High-dose biotin
	Cannabis and other antispastic agents
	Minocycline
	Extracranial vein angioplasty
	Cholecalciferol
	Daclizumab high-yield process
	Clemastine fumarate
	Interferon-β
	Oral BG-12
	Balance and eye-movement exercises
	Noninvasive tongue stimulation with intensive cognitive/physical rehabilitation
Risk factors	Modifiable lifestyle: coffee consumption, breastfeeding, ovulatory years, vaccination, vitamin D, sun exposure, diet (sodium intake and low saturated fat diet), concussion, latitude, physical comorbidities, exercise, smoking, Helicobacter pylori infection, HIV infection
	Genetic factors: nuclear receptor NR1H3, vitamin D receptor polymorphisms, single nucleotide polymorphisms associated with MS risk, the results of the genes and environment in multiple sclerosis (GEMS) project in the United States